Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Bioprinting and 3D Printing in the Life Sciences Europe

Adam Perriman's Biography



Adam Perriman, Associate Professor of Biodesign, Reader in Biomaterials, University of Bristol

Adam Perriman is an Associate Professor of Biomaterials at the University of Bristol and an Engineering and Physical Sciences Research Council (EPSRC) Early Career Fellow. He is internationally distinguished for his pioneering research on the construction and study of novel synthetic biomolecular systems. His interests are acutely interdisciplinary, and span the fields of chemistry, synthetic biology and tissue engineering. His significant advances in these areas have resulted in numerous invited presentations at conferences and colloquia and has generated extensive media coverage and featured in the popular science magazines New Scientist, Pop Sci and The Royal Society of Chemistry’s Chemistry World. In 2010 and 2016 he was interviewed on BBC4, which was broadcast nationally. He has published much of his research in high-impact scientific journals, including Nature Chemistry, Nature Communications, and Advanced Materials. In 2015, he was named a Wellcome Trust Frontiers Innovator, and in 2016, he received the British Biophysical Society Young Investigator's Award and Medal. In December of 2017, he foundered the new cell therapy company, CytoSeek.

Adam Perriman Image

Stem Cell Bioprinting using a Hybrid Microporous Bioink

Tuesday, 17 October 2017 at 09:45

Add to Calendar ▼2017-10-17 09:45:002017-10-17 10:45:00Europe/LondonStem Cell Bioprinting using a Hybrid Microporous BioinkBioprinting and 3D Printing in the Life Sciences Europe in Cripps Court, Magdalene College, Cambridge, UK Cripps Court, Magdalene College, Cambridge, UK SELECTBIOenquiries@selectbiosciences.com

We describe the development and testing of a highly effective hybrid gel-based bio-ink, which we use to print a range of macroscopic structures as well as fine crosshatched motifs. Significantly, we demonstrate that the mesenchymal stem cell-laden bio-ink can be used to rapidly print structures while maintaining high levels of cell viability (>80%), and that the constructs (including a life-sized trachea ring) can be used in cartilage and bone tissue engineering, giving rise to well-distributed extracellular matrix components (collagen, glycosaminoglycan, calcium and phosphate) within the printed geometry.


Add to Calendar ▼2017-10-17 00:00:002017-10-18 00:00:00Europe/LondonBioprinting and 3D Printing in the Life Sciences EuropeBioprinting and 3D Printing in the Life Sciences Europe in Cripps Court, Magdalene College, Cambridge, UK Cripps Court, Magdalene College, Cambridge, UK SELECTBIOenquiries@selectbiosciences.com